Fundraising is a game of battleship and even more so in as high-risk a domain as Antimicrobial Resistance. But with the recent Lancet paper, investors and stakeholders are waking up to the need for investment in deep science to prevent a possible apocalyptic infection that no drugs can treat.
This week we have an exciting CCAMP - CARB-X Webinar on Strategizing Fundraising for AMR innovations with prominent AMR innovators
Dr Chandrasekhar Nair, Co-Founder & CTO Molbio Diagnostics, Dr Janani Venkatraman, Founder, Director & CEO Biomoneta Research & seasoned foreign venture capitalist in India, Mayur Shah, Head of Japanese VC firm Beyond Next Ventures
Date & Time: Thursday, 24th Feb, 11:30am - 12:45pm
Registrations are on! Sign up at https://t.co/RpT9XOepTM
Date:
Thursday, February 24, 2022
Banner:
